Tinnitus in patients on therapy with proton pump inhibitors (PPI) and in PPI non-users

被引:2
|
作者
Pirodda, Antonio [1 ]
Raimondi, Maria Chiara [1 ]
Cicero, Arrigo Francesco Giuseppe [2 ]
Rosticci, Martina [2 ]
Rinaldi, Elisa Rebecca [2 ]
Bellacosa, Lara [2 ]
Stanghellini, Vincenzo [2 ]
Borghi, Claudio [2 ]
机构
[1] Univ Bologna, Dept Expt Diagnost & Specialty Med, Via Massarenti,9, I-40138 Bologna, Italy
[2] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
关键词
proton pump inhibitors; inner ear disorders;
D O I
10.3109/21695717.2014.902554
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Objective: We wished to observe the prevalence of tinnitus in subjects on therapy with proton pump inhibitors (PPI). A possible favourable effect of the commercially available proton pump inhibitors (PPI) on inner ear disorders was recently outlined. In order to investigate this possibility the prevalence of tinnitus (an indicator of labyrinthine sufferance in general terms) among PPI users and non-users was analysed. Study design: An observational study on the prevalence of tinnitus among PPI users and non-users was carried out. Between June 2012 and March 2013 a cohort of consecutive patients who were referred to S. Orsola-Malpighi University Hospital of Bologna for various non-audiological disorders was included in the study. Each patient was instructed to complete an anonymous validated questionnaire on hearing problems. The Ethics Committee of S. Orsola Malpighi Hospital had been informed about collection of the data. Results: In the age class 60-69 years there was a statistically significant lower prevalence of non-specified tinnitus in PPI users, compared to non-users. Conclusion: Even if a favourable effect on this symptom derived from the treatment of gastroesophageal reflux cannot be excluded, a direct regulatory effect on inner ear homeostasis, through the action of PPI on the gastric type proton pump of the inner ear, cannot be ruled out. Another possible effect could depend upon vasomotor activity enabling better peripheral perfusion without significantly modifying blood pressure values, thus contributing to the stabilization of inner ear oxygenation. Additionally, a certain degree of anti-inflammatory effect could yield another kind of non-specific favourable influx. In conclusion, even if the supposed benefit deriving from the use of PPI in treating inner ear affections of unknown origin is still unclear with regard to its significance and limits, the reported results demonstrate that longitudinal studies could be useful in order to verify the possibility of a new therapeutic perspective.
引用
收藏
页码:84 / 87
页数:4
相关论文
共 50 条
  • [41] The effect of proton pump inhibitors on glycaemic control in diabetic patients
    Rajput, Muhammad Ali
    Ali, Fizzah
    Zehra, Tabassum
    Zafar, Shahid
    Kumar, Gunesh
    JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2020, 15 (03): : 218 - 223
  • [43] Effect of proton pump inhibitors on glycemic control in patients with diabetes
    Takebayashi, Kohzo
    Inukai, Toshihiko
    WORLD JOURNAL OF DIABETES, 2015, 6 (10): : 1122 - 1131
  • [44] Risk of dementia in elderly patients with the use of proton pump inhibitors
    Haenisch, Britta
    von Holt, Klaus
    Wiese, Birgitt
    Prokein, Jana
    Lange, Carolin
    Ernst, Annette
    Brettschneider, Christian
    Koenig, Hans-Helmut
    Werle, Jochen
    Weyerer, Siegfried
    Luppa, Melanie
    Riedel-Heller, Steffi G.
    Fuchs, Angela
    Pentzek, Michael
    Weeg, Dagmar
    Bickel, Horst
    Broich, Karl
    Jessen, Frank
    Maier, Wolfgang
    Scherer, Martin
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2015, 265 (05) : 419 - 428
  • [45] A Prospective Randomized Clinical Trial of Combination Therapy with Proton Pump Inhibitors and Mucolytics in Patients with Laryngopharyngeal Reflux
    Chae, Minsuk
    Jang, Dong Hyuk
    Kim, Ho Chan
    Kwon, Minsu
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2020, 129 (08) : 781 - 787
  • [46] Proton pump inhibitors to control phosphorus levels in hemodialysis patients
    Hojati, Amineh
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2025, 16 (01) : 185 - 186
  • [47] Deprescribing proton pump inhibitors: A study in hospitalized patients in Slovenia
    Ravbar, Nina
    Kos, Mojca Kerec
    Jost, Maja
    Lipovec, Nanca Cebron
    Knez, Lea
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2023, 61 (07) : 306 - 314
  • [48] Discontinuation of Proton Pump Inhibitors in Patients With Chronic Kidney Disease
    Mertz, Amanda
    Cooney, Danielle
    Rahman, Mahboob
    Lacey, Christopher
    Burant, Christopher J.
    Desai, Niraj
    HOSPITAL PHARMACY, 2021, 56 (04) : 308 - 313
  • [49] Cardiovascular and non-cardiovascular concerns with proton pump inhibitors: Are they safe?
    Corsonello, Andrea
    Lattanzio, Fabrizia
    TRENDS IN CARDIOVASCULAR MEDICINE, 2019, 29 (06) : 353 - 360
  • [50] Endoscopic and histological characteristics in patients with eosinophilic esophagitis responsive and non-responsive to proton pump inhibitors
    Vieira, Gabriela Guimaraes
    Mendez Ribeiro, Luciana Bandeira
    Truppel, Sabine Kruger
    Rosario Filho, Nelson Augusto
    Vieira, Mario Cesar
    JORNAL DE PEDIATRIA, 2020, 96 (05) : 638 - 643